2 terminated, 1 unknown. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Unknown 1 |
Follow MD1003: new trials by email Literature Review of MD1003 trials Research Report on MD1003
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects MD1003, Moxifloxacin 400mg, Placebo for MD1003 - Healthy Volunteers | Phase 1 | Unknown | MedDay Pharmaceuticals SA | 64 | 2019-11-11 | 2020-02-20 |
| HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Hepatic Impairment of Moderate Child Pugh Category | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 15 | 2019-10-11 | 2020-05-13 |
| RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects MD1003 - Healthy Volunteers, Impaired Renal Function | Phase 1 | Terminated | MedDay Pharmaceuticals SA | 24 | 2019-10-09 | 2020-05-13 |
France (2) · Hungary (2) · United Kingdom (1)
Yves Donazzolo, MD (2) · Muna Albayaty, MD (1)
2019 (2)